Financials
Financial year 2025
PHARMACIES ENGELS from Malmedy, company number BE0821492208, closed financial year 2025 with a result of € 187,380 after tax. For that financial year PHARMACIES ENGELS recorded a gross margin of € 733,151 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 237,587 to € 187,380. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 1.1 million
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 187,380
▼ 21% vs 2024
Profit after tax over the fiscal year.
€ 305,566
▼ 52% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 57,833 paid out
31 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
6.1
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 400,106
▲ 7% vs 2024
€ 65,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 57,792
▼ 20% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 298,736
▲ 92% vs 2024
€ 35,981 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 101,941
▼ 47% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 98,777
▼ 15% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 595,821 | € 714,779 | € 740,431 | € 733,151 | ▼ 1% |
| Profit after taxes | € 132,744 | € 191,069 | € 237,587 | € 187,380 | ▼ 21% |
| Equity | € 600,321 | € 764,557 | € 926,311 | € 1,055,858 | ▲ 14% |
| Total debts | € 290,813 | € 256,799 | € 513,864 | € 632,709 | ▲ 23% |
| Cash | € 408,612 | € 319,245 | € 640,073 | € 305,566 | ▼ 52% |
| Retained profit | € 581,721 | € 745,957 | € 907,711 | € 1,037,258 | ▲ 14% |
| Dividend | € 51,800 | € 26,833 | € 75,833 | € 57,833 | ▼ 24% |
| Bank debt | € 91,498 | € 44,553 | € 155,969 | € 298,736 | ▲ 92% |
| Balance sheet total | € 891,134 | € 1,026,955 | € 1,444,375 | € 1,691,367 | ▲ 17% |
| Employees (FTE) | 5.8 | 5.8 | 6 | 6.1 | ▲ 0.1 |
Key figures of PHARMACIES ENGELS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIES ENGELS?
What happened at PHARMACIES ENGELS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 187,380 (▼ 21% vs 2024). Source: NBB ↗
- New establishment in Malmedy. KBO
- New establishment in Malmedy. KBO
- Start of the company according to the CBE. KBO
In short
From € 132,744 profit in 2022 to € 187,380 profit in 2025.
Paid € 313,614 in corporate taxes since 2022.
Best year ever: 2024, with € 237,587 profit.
On average € 120,200 of value added per employee in 2025.
Management
Behind PHARMACIES ENGELS is Frédéric ENGELS.
Directors
According to the 2025 annual accounts
Frédéric ENGELS
Director
Establishments
Establishment units
Physical locations of this company
Rue Neuve 48
4960 Malmedy
Rue Devant les Religieuses 23
4960 Malmedy
Active since 16 December 2009
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0821.492.208
- VAT number
- BE 0821.492.208
- Registered office
- Rue Neuve 48, 4960 Malmedy
- Names & denominations
- PHARMACIES ENGELS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 December 2009
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen